A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.


Updates from The Motley Fool

Latest updates on Cepheid from Fool.com.
Why Cepheid Is Skyrocketing Today

Image source: Getty Images. What happened Shareholders of  Cepheid  (NASDAQ: CPHD), a molecular d...

Why Cepheid Stock Nosedived

Although we don't believe in timing the market or panicking over market movements, we do like to ...

Why Cepheid Shares Are Climbing

Although we don't believe in timing the market or panicking over market movements, we do like to ...

Why Cepheid Shares Popped

Although we don't believe in timing the market or panicking over market movements, we do like to ...

Why Cepheid Shares Dropped

Although we don't believe in timing the market or panicking over market movements, we do like to ...

Why Cepheid Shares Imploded

Although we don't believe in timing the market or panicking over market movements, we do like to ...

2 Positive Signs for Cepheid

Cepheid ( Nasdaq: CPHD     ) carries $32.2 million of goodwill and other intangibles on its ba...

Amass a Fortune With These Stocks

You don't need the  investing acumen of Warren Buffett  or the riches of a trust-fund baby to ac...

5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's b...

These Cold Stocks Are Heating Up

When a stock's share price is lower than a North Dakota thermometer in February, investors tend t...

Are Shorts Watching Qiagen?

There's no foolproof way to know the future for Qiagen ( Nasdaq: QGEN     ) or any other comp...



Stock Performance

View Interactive CPHD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cepheid.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): ($0.51)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cepheid.
CAPS Rating 2 out of 5
 
240 Outperform
23 Underperform
CAPS All Stars
 
45 Outperform
3 Underperform

How do you think Cepheid will perform against the market?



You pick for Cepheid is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John L. Bishop, CEO

45% Approve

Based on 37 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cepheid.

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

  • Exchange: NASDAQ
  • Sector: Technology
  • Industry: Electronics